Overexpression of hepatocyte growth factor in SBMA model mice has an additive effect on combination therapy with castration.

[1]  T. Kinoshita,et al.  Hepatocyte Growth Factor , 2014 .

[2]  G. Sobue,et al.  Paeoniflorin eliminates a mutant AR via NF-YA-dependent proteolysis in spinal and bulbar muscular atrophy. , 2014, Human molecular genetics.

[3]  G. Sobue,et al.  Pathogenesis and therapy of spinal and bulbar muscular atrophy (SBMA) , 2012, Progress in Neurobiology.

[4]  G. Sobue,et al.  Viral delivery of miR-196a ameliorates the SBMA phenotype via the silencing of CELF2 , 2012, Nature Medicine.

[5]  Wakana Ohya-Shimada,et al.  Overexpression of HGF attenuates the degeneration of Purkinje cells and Bergmann glia in a knockin mouse model of spinocerebellar ataxia type 7 , 2012, Neuroscience Research.

[6]  R. Morishita,et al.  Experimental and clinical application of plasmid DNA in the field of central nervous diseases. , 2011, Current gene therapy.

[7]  S. Tsuji,et al.  Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial , 2010, The Lancet Neurology.

[8]  K. Fischbeck,et al.  Clinical features of spinal and bulbar muscular atrophy , 2009, Brain : a journal of neurology.

[9]  K. Fischbeck,et al.  Overexpression of IGF-1 in Muscle Attenuates Disease in a Mouse Model of Spinal and Bulbar Muscular Atrophy , 2009, Neuron.

[10]  G. V. Vande Woude,et al.  Novel Therapeutic Inhibitors of the c-Met Signaling Pathway in Cancer , 2009, Clinical Cancer Research.

[11]  N. Hay,et al.  Is Akt the "Warburg kinase"?-Akt-energy metabolism interactions and oncogenesis. , 2009, Seminars in cancer biology.

[12]  K. Fischbeck,et al.  Akt blocks ligand binding and protects against expanded polyglutamine androgen receptor toxicity. , 2007, Human molecular genetics.

[13]  K. Kaibuchi,et al.  Ras regulates neuronal polarity via the PI3-kinase/Akt/GSK-3beta/CRMP-2 pathway. , 2006, Biochemical and biophysical research communications.

[14]  G. Sobue,et al.  17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration , 2005, Nature Medicine.

[15]  Fumiaki Tanaka,et al.  Widespread nuclear and cytoplasmic accumulation of mutant androgen receptor in SBMA patients. , 2005, Brain : a journal of neurology.

[16]  Y. Rao,et al.  Both the Establishment and the Maintenance of Neuronal Polarity Require Active Mechanisms Critical Roles of GSK-3β and Its Upstream Regulators , 2005, Cell.

[17]  A. Davies,et al.  HGF regulates the development of cortical pyramidal dendrites , 2004, Development.

[18]  G. Sobue,et al.  Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy , 2003, Nature Medicine.

[19]  G. Sobue,et al.  Testosterone Reduction Prevents Phenotypic Expression in a Transgenic Mouse Model of Spinal and Bulbar Muscular Atrophy , 2002, Neuron.

[20]  Woong Sun,et al.  Overexpression of HGF Retards Disease Progression and Prolongs Life Span in a Transgenic Mouse Model of ALS , 2002, The Journal of Neuroscience.

[21]  J. Bloch,et al.  Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. , 2000, Science.

[22]  R. Klein,et al.  Hepatocyte growth factor, a versatile signal for developing neurons , 1999, Nature Neuroscience.

[23]  Fumiaki Tanaka,et al.  Nuclear inclusions of the androgen receptor protein in spinal and bulbar muscular atrophy , 1998, Annals of neurology.

[24]  W. Kennedy,et al.  Progressive proximal spinal and bulbar muscular atrophy of late onset , 1998, Neurology.

[25]  M. Hanson,et al.  Hepatocyte Growth Factor/Scatter Factor Is an Axonal Chemoattractant and a Neurotrophic Factor for Spinal Motor Neurons , 1996, Neuron.

[26]  K. Matsumoto,et al.  Neurotrophic effect of hepatocyte growth factor on central nervous system neurons in vitro , 1996, Journal of neuroscience research.

[27]  P. Boros,et al.  Hepatocyte growth factor: a multifunctional cytokine , 1995, The Lancet.

[28]  K. Fischbeck,et al.  Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy , 1991, Nature.

[29]  K. Tashiro,et al.  Molecular cloning and expression of human hepatocyte growth factor , 1989, Nature.

[30]  T. Nakamura,et al.  Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. , 1984, Biochemical and biophysical research communications.

[31]  W. Russell,et al.  Partial characterization of a hepatocyte growth factor from rat platelets , 1984, Journal of cellular physiology.

[32]  M Alter,et al.  Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait. , 1968, Neurology.

[33]  G. Michalopoulos,et al.  Liver regeneration. , 2005, Advances in biochemical engineering/biotechnology.

[34]  G. Sobue,et al.  Katsuno, M. et al. Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy. Nat. Med. 9, 768−773 , 2003 .

[35]  G. Pavlath,et al.  Hepatocyte growth factor affects satellite cell activation and differentiation in regenerating skeletal muscle. , 2000, American journal of physiology. Cell physiology.

[36]  G. Michalopoulos,et al.  Liver Regeneration , 1997, Science.